Adrianne Woods
Overview
Explore the profile of Adrianne Woods including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
94
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yan B, Lee J, Srinivasan S, Shi Q, Dou D, Davuluri S, et al.
bioRxiv
. 2025 Feb;
PMID: 39896599
Four out of five patients with autoimmune diseases are women. The XIST ribonucleoprotein (RNP) complex, comprising the female-specific long noncoding RNA XIST and over 100 associated proteins, may drive several...
2.
Kuchinad K, Kim J, Woods A, Leatherman G, Gutierrez-Alamillo L, Mayes M, et al.
Ann Rheum Dis
. 2024 Jul;
83(11):1513-1521.
PMID: 39019570
Objective: To understand if autoantibodies account for racial variation in disease severity, we compared autoantibody distribution and associated phenotype between self-identified black and white systemic sclerosis (SSc) patients. Methods: 803...
3.
Coursen J, Tuhy T, Naranjo M, Woods A, Hummers L, Shah A, et al.
Am J Physiol Lung Cell Mol Physiol
. 2024 Apr;
327(1):L54-L64.
PMID: 38651694
We sought to investigate differential metabolism in patients with systemic sclerosis (SSc) who develop pulmonary arterial hypertension (PAH) versus those who do not, as a method of identifying potential disease...
4.
Kim J, Woods A, Gutierrez-Alamillo L, Laffoon M, Wigley F, Hummers L, et al.
Arthritis Rheumatol
. 2023 Jul;
76(1):68-77.
PMID: 37488962
Objectives: We examined whether an array of scleroderma autoantibodies associates with risk of cancer and could be useful tools for risk stratification. Methods: Scleroderma cancer cases and scleroderma controls without...
5.
Hinze A, Perin J, Woods A, Hummers L, Wigley F, Mukherjee M, et al.
Arthritis Rheumatol
. 2021 Dec;
74(5):849-859.
PMID: 34927390
Objective: To determine the independent risk factors for diastolic dysfunction (DD) in patients with systemic sclerosis (SSc) and to evaluate the impact of DD on mortality. Methods: SSc patients enrolled...
6.
Shah D, Hirpara R, Poelman C, Woods A, Hummers L, Wigley F, et al.
Arthritis Care Res (Hoboken)
. 2018 Jan;
70(10):1517-1524.
PMID: 29316366
Objective: We examined systemic sclerosis (SSc) patients with breast cancer to identify the prevalence of radiation complications and to examine outcomes in SSc patients who received radiation therapy as part...
7.
Gelber A, Manno R, Shah A, Woods A, Le E, Boin F, et al.
Medicine (Baltimore)
. 2013 Jun;
92(4):191-205.
PMID: 23793108
Experience suggests that African Americans may express autoimmune disease differently than other racial groups. In the context of systemic sclerosis (scleroderma), we sought to determine whether race was related to...
8.
Mittoo S, Wigley F, Wise R, Woods A, Xiao H, Hummers L
Open Rheumatol J
. 2011 May;
5:1-6.
PMID: 21552414
Background: Scleroderma (SSc) patients with active interstitial lung disease (ILD) experience a decline in lung function and increased mortality; cyclophosphamide (CYC) therapy may stabilize lung function at one and two...
9.
Lam G, Hummers L, Woods A, Wigley F
J Rheumatol
. 2007 Jul;
34(7):1636-7.
PMID: 17611970
No abstract available.